These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16608108)

  • 1. [Use of reminyl (galantamine) in the treatment of dementia].
    Voronkova KV; Pylaeva OA; Mazal'skaia OV; Lemeshko ID; Petrukhin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(3):26-30. PubMed ID: 16608108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of galantamine in Alzheimer's disease associated with vascular dementia (according to the study of T. Erkinjuntti group)].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):65-7. PubMed ID: 19938276
    [No Abstract]   [Full Text] [Related]  

  • 3. [Galantamine (reminyl) in the treatment of severe Alzheimer's disease].
    Gavrilova SI; Kolykhanov IV; Kalyn IaB; Selezneva ND
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7):57-61. PubMed ID: 19672237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Galantamine (reminyl) in the treatment of Alzheimer's disease and vascular dementia].
    Gavrilova SI; Zharikov GA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(12):59-65. PubMed ID: 14763262
    [No Abstract]   [Full Text] [Related]  

  • 5. Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.
    Small G; Erkinjuntti T; Kurz A; Lilienfeld S
    CNS Drugs; 2003; 17(12):905-14. PubMed ID: 12962529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galantamine: use in Alzheimer's disease and related disorders.
    Bullock R
    Expert Rev Neurother; 2004 Mar; 4(2):153-63. PubMed ID: 15853556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacological rationale for treating vascular dementia with galantamine (Reminyl).
    Maelicke A
    Int J Clin Pract Suppl; 2001 May; (120):24-8. PubMed ID: 11406923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galantamine: a review of its use in Alzheimer's disease and vascular dementia.
    Corey-Bloom J
    Int J Clin Pract; 2003 Apr; 57(3):219-23. PubMed ID: 12723727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galantamine for the treatment of BPSD in Thai patients with possible Alzheimer's disease with or without cerebrovascular disease.
    Tangwongchai S; Thavichachart N; Senanarong V; Poungvarin N; Phanthumchinda K; Praditsuwan R; Nidhinandana S; Chankrachang S
    Am J Alzheimers Dis Other Demen; 2008 Dec-2009 Jan; 23(6):593-601. PubMed ID: 18845693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease.
    Brodaty H; Corey-Bloom J; Potocnik FC; Truyen L; Gold M; Damaraju CR
    Dement Geriatr Cogn Disord; 2005; 20(2-3):120-32. PubMed ID: 15990426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of reminyl (galantamine) in the treatment of probable vascular dementia].
    Mokhova OI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(9):77-9. PubMed ID: 19911468
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial.
    Kertesz A
    Curr Neurol Neurosci Rep; 2002 Nov; 2(6):503-4. PubMed ID: 12359103
    [No Abstract]   [Full Text] [Related]  

  • 13. [Reminyl efficacy in dementia with Levi bodies].
    Levin OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(10):15-21. PubMed ID: 16281374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial.
    Erkinjuntti T; Kurz A; Gauthier S; Bullock R; Lilienfeld S; Damaraju CV
    Lancet; 2002 Apr; 359(9314):1283-90. PubMed ID: 11965273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galantamine for vascular dementia: some answers, some questions.
    Schneider LS
    Lancet; 2002 Apr; 359(9314):1265-6. PubMed ID: 11965268
    [No Abstract]   [Full Text] [Related]  

  • 16. Broad therapeutic benefits in patients with probable vascular dementia or Alzheimer's disease with cerebrovascular disease after treatment with galantamine.
    Erkinjuntti T
    Eur J Neurol; 2002 Sep; 9(5):545. PubMed ID: 12220392
    [No Abstract]   [Full Text] [Related]  

  • 17. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
    Masterman D
    Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial.
    Marder K
    Curr Neurol Neurosci Rep; 2002 Sep; 2(5):389-90. PubMed ID: 12169216
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential efficacy of treatment with acetylcholinesterase inhibitors in patients with mild and moderate Alzheimer's disease over a 6-month period.
    López-Pousa S; Turon-Estrada A; Garre-Olmo J; Pericot-Nierga I; Lozano-Gallego M; Vilalta-Franch M; Hernández-Ferràndiz M; Morante-Muñoz V; Isern-Vila A; Gelada-Batlle E; Majó-Llopart J
    Dement Geriatr Cogn Disord; 2005; 19(4):189-95. PubMed ID: 15677866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broad therapeutic benefits in patients with probable vascular dementia or Alzheimer's disease with cerebrovascular disease treated with galantamine.
    Lilienfeld S; Kurz A
    Ann N Y Acad Sci; 2002 Nov; 977():487-92. PubMed ID: 12480790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.